OPC: Approved the result of stock issuance for increasing capital

The Board resolution dated August 02, 2022, the BOD of OPC Pharmaceutical Joint Stock Company approved the following issues:

1. Approved the result of stock issuance for increasing capital from the owner’s equity:

- Stock name: OPC Pharmaceutical Joint Stock Company

- Stock type: common share

- Par value: 10,000 dongs/share

- Number of shares expected to be issued: 37,473,965 shares

- Number of distributed shares: 37,473,612 shares

- Fractional shares volume: 353 shares

- Total shares after the issuance: 64,050,892 shares; Of which:

+ Number of outstanding shares: 64,050,892 shares

+ Number of treasury shares: 0 share.

2. Approved the change of charter with new charter capital.

HOSE

>   CCL: SSC approved the result of stock issuance for dividend payment (04/08/2022)

>   DIG: Approved the result of share issuance (04/08/2022)

>   DIG: Report on result of share issuance (04/08/2022)

>   PNJ: Stock issuance under ESOP (02/08/2022)

>   HSL: Adjusting result of stock issuance for dividend payment (01/08/2022)

>   LBM: Result of stock issuance for increasing capital (01/08/2022)

>   MWG: Increasing capital in subsidiaries (01/08/2022)

>   BCG: Report on the progress of using capital from the offering (01/08/2022)

>   GEX: Report on the progress of using capital from the offering (01/08/2022)

>   HAX: Increasing charter capital (01/08/2022)